AR and Alzheimer disease: In contrast to above results, knocking down endogenous LRIG1 using pGIPZ-shLRIG1 (Supplementary Fig. 5c) in 3 AR+, AD PCa cells, VCaP, LAPC4, and LAPC9, significantly promoted tumor regeneration (Fig. 3a–c).